1. 1 WHO Classification of Tumours, Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds): 4th ed, Lyon, IARC, 2008
2. Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001–2006
3. 3 Liu Z, Dong HY, Gorczyca W, Tsang P, Cohen P, et al.: CD5- mantle cell lymphoma. Am J Clin Pathol 118:216-224, 2002
4. 4 Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD: Mantle cell lymphoma : a clinicopathologic study of 80 cases. Blood 89:2067-2078, 1997
5. 5 Tiemann M, Schrader C, Klapper W, Dreyling NH, Campo E, et al.: Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL) : a clinicopathological study from the European MCL Network. Br J Haematol 142:29-38, 2005